Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 490, Issue 1-2, Pages 22-31Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2015.05.008
Keywords
Curcumin; Piperine; SMEDDS; Preparation and characterization; Stability; Anti-colitis activity
Categories
Funding
- National Natural Science Foundation of China [30801549]
- Innovation Team Development Program of Beijing University of Chinese Medicine [2011-CXTD-13]
- Independent Project of Beijing University of Chinese Medicine [2014-JYBZZ-XS-087]
Ask authors/readers for more resources
Curcumin (CUR) is a poorly water-soluble drug and its absorption is very low. In this study, CUR and piperine (PIP) were co-encapsulated into the nanoformulation called self-microemulsifying drug delivery system (SMEDDS) to improve the stability and water-solubility of CUR and enhance its anti-colitis activity. The formulation of CUR-PIP-SMEDDS was prepared to encapsulate two hydrophobic components CUR and PIP, and then was characterized by assessing appearance, morphology, particle size, zeta potential and drug encapsulation efficiency. The appearance of CUR-PIP-SMEDDS remained clarified and transparent, and the microemulsion droplets appeared spherical without aggregation. The mean size of microemulsion droplet formed from CUR-PIP-SMEDDS was 15.87 +/- 0.76 nm, and the drug encapsulation efficiency of SMEDDS for CUR and PIP were (94.34 +/- 2.18)% and (90.78 +/- 2.56)%, respectively. The vitro stability investigation of CUR-PIP-SMEDDS in colon tissue suggested that using SMEDDS as a delivery vehicle and co-encapsulated with PIP, CUR was more stable than drug solution in colons site. Meanwhile, the anti-inflammatory activity of CUR-PIP-SMEDDS was evaluated on DSS-induced colitis model. The results showed that CUR-PIP-SMEDDS exhibited definite anti-colitis activity by directing CUR-PIP-SMEDDS to inflammatory colon tissue through retention enema administration. Our study illustrated that the developed CUR-PIP-SMEDDS formulation was a potential carrier for developing colon-specific drug delivery system of CUR for ulcerative colitis treatment. (C) 2015 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available